Rasburicase in Patients at Risk for Tumor Lysis Syndrome

Clinical trial NCT00628628 · COMPLETED

Trial details

NCT number: NCT00628628
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Tumor Lysis Syndrome

Start date: 2008-01-01
Primary completion: 2012-05-01
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.